New Breast Cancer Treatments: Pills, Shorter Regimens, Personalized Plans
Cleveland News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
New studies from 2025 unveil promising breast cancer treatments, including a pill combo delaying disease progression in advanced cases, a shorter regimen for aggressive triple-negative tumors, and personalized plans using blood tests and tumor markers. A key trial showed giredestrant combined with everolimus outperforming standard hormone therapy plus everolimus in metastatic estrogen receptor-positive, HER2-negative breast cancer. These breakthroughs offer hope for better outcomes and fewer side effects, though they remain experimental. Meanwhile, for triple-negative breast cancer, researchers cut treatment to two immunotherapy doses and radiation before chemo, achieving similar cancer clearance at surgery as longer trials but halving serious side effects. Ongoing work at major conferences pushes personalized care further, with blood tests spotting tumor DNA helping adjust therapies early for hormone-resistant cases.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/5a5ce557e99f29fd